Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa.

We report the case of a 39-yearold African lady with BSLE, who was successfully treated with low-dose rituximab (500 mg 2 weeks apart), healing her skin lesions at one year post-treatment. Low-dose rituximab may be as effective as standard dosing for the treatment of severe bullous SLE and is recommended in low resource settings. PMID: 32700878 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32700878?dopt=Abstract

Source: Reumatismo - July 22, 2020 Category: Rheumatology Authors: Akpabio AA, Otike-Odibi BI Tags: Reumatismo Source Type: research